VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 330 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2017. The put-call ratio across all filers is 1.24 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $5,393,000 | -4.7% | 488,988 | +25.4% | 0.18% | +34.6% |
| Q4 2016 | $5,660,000 | -50.5% | 389,796 | -16.3% | 0.13% | -42.9% |
| Q3 2016 | $11,438,000 | +51.6% | 465,911 | +24.3% | 0.23% | +79.2% |
| Q2 2016 | $7,547,000 | -53.0% | 374,737 | -38.6% | 0.13% | -54.1% |
| Q1 2016 | $16,062,000 | -74.5% | 610,689 | -1.5% | 0.28% | -56.9% |
| Q4 2015 | $63,028,000 | +59.2% | 620,056 | +179.4% | 0.66% | +73.1% |
| Q3 2015 | $39,587,000 | -7.5% | 221,925 | +15.2% | 0.38% | -3.3% |
| Q2 2015 | $42,813,000 | -11.4% | 192,720 | -20.8% | 0.39% | -18.5% |
| Q1 2015 | $48,326,000 | -11.1% | 243,306 | -35.9% | 0.48% | +41.5% |
| Q4 2014 | $54,360,000 | -21.5% | 379,840 | -28.0% | 0.34% | -0.9% |
| Q3 2014 | $69,213,000 | +175.7% | 527,538 | +165.0% | 0.34% | +185.8% |
| Q2 2014 | $25,105,000 | +52.7% | 199,054 | +59.6% | 0.12% | +31.9% |
| Q1 2014 | $16,442,000 | -14.3% | 124,716 | -23.7% | 0.09% | -11.7% |
| Q4 2013 | $19,183,000 | +23.3% | 163,399 | +9.6% | 0.10% | +7.3% |
| Q3 2013 | $15,561,000 | +23.7% | 149,141 | +2.0% | 0.10% | +24.7% |
| Q2 2013 | $12,582,000 | – | 146,169 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
| Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
| Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
| Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
| FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
| Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
| Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
| HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
| LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
| Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |